vs
Bionano Genomics, Inc.（BNGO）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Bionano Genomics, Inc.的7.8倍（$62.1M vs $8.0M）。Cytek Biosciences, Inc.净利率更高（-70.9% vs -99.8%，领先28.8%）。Cytek Biosciences, Inc.同比增速更快（8.1% vs -2.6%）。过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs -4.8%）
Bionano Genomics是一家基因组技术企业，开发并销售专有光学基因组测绘技术及相关诊断解决方案，可高精度检测基因组大型结构变异，服务全球学术研究机构、生物制药企业与临床诊断实验室，产品应用于肿瘤、罕见病研究等领域。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
BNGO vs CTKB — 直观对比
营收规模更大
CTKB
是对方的7.8倍
$8.0M
营收增速更快
CTKB
高出10.7%
-2.6%
净利率更高
CTKB
高出28.8%
-99.8%
两年增速更快
CTKB
近两年复合增速
-4.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $8.0M | $62.1M |
| 净利润 | $-7.9M | $-44.1M |
| 毛利率 | 42.8% | 52.9% |
| 营业利润率 | -107.4% | -9.0% |
| 净利率 | -99.8% | -70.9% |
| 营收同比 | -2.6% | 8.1% |
| 净利润同比 | 60.6% | -557.1% |
| 每股收益（稀释后） | $-0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNGOCTKB
| Q4 25 | $8.0M | $62.1M | ||
| Q3 25 | $7.4M | $52.3M | ||
| Q2 25 | $6.7M | $45.6M | ||
| Q1 25 | $6.5M | $41.5M | ||
| Q4 24 | $8.2M | $57.5M | ||
| Q3 24 | $6.1M | $51.5M | ||
| Q2 24 | $7.8M | $46.6M | ||
| Q1 24 | $8.8M | $44.9M |
净利润BNGOCTKB
| Q4 25 | $-7.9M | $-44.1M | ||
| Q3 25 | $-8.5M | $-5.5M | ||
| Q2 25 | $-6.9M | $-5.6M | ||
| Q1 25 | $-3.1M | $-11.4M | ||
| Q4 24 | $-20.1M | $9.6M | ||
| Q3 24 | $-44.2M | $941.0K | ||
| Q2 24 | $-16.2M | $-10.4M | ||
| Q1 24 | $-31.4M | $-6.2M |
毛利率BNGOCTKB
| Q4 25 | 42.8% | 52.9% | ||
| Q3 25 | 45.7% | 52.7% | ||
| Q2 25 | 51.6% | 52.3% | ||
| Q1 25 | 45.5% | 48.6% | ||
| Q4 24 | 41.9% | 58.5% | ||
| Q3 24 | -139.1% | 56.3% | ||
| Q2 24 | 33.3% | 54.6% | ||
| Q1 24 | 32.2% | 51.3% |
营业利润率BNGOCTKB
| Q4 25 | -107.4% | -9.0% | ||
| Q3 25 | -115.9% | -17.6% | ||
| Q2 25 | -115.8% | -23.3% | ||
| Q1 25 | -131.1% | -36.1% | ||
| Q4 24 | -146.3% | 5.2% | ||
| Q3 24 | -722.9% | -8.2% | ||
| Q2 24 | -219.0% | -18.3% | ||
| Q1 24 | -354.9% | -23.9% |
净利率BNGOCTKB
| Q4 25 | -99.8% | -70.9% | ||
| Q3 25 | -115.4% | -10.5% | ||
| Q2 25 | -101.8% | -12.2% | ||
| Q1 25 | -48.0% | -27.5% | ||
| Q4 24 | -246.5% | 16.8% | ||
| Q3 24 | -728.6% | 1.8% | ||
| Q2 24 | -208.8% | -22.4% | ||
| Q1 24 | -358.3% | -13.8% |
每股收益（稀释后）BNGOCTKB
| Q4 25 | $-0.12 | — | ||
| Q3 25 | $-1.59 | — | ||
| Q2 25 | $-1.99 | — | ||
| Q1 25 | $-1.15 | — | ||
| Q4 24 | $-7.05 | — | ||
| Q3 24 | $-30.92 | — | ||
| Q2 24 | $-14.41 | — | ||
| Q1 24 | $-35.75 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $90.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $44.4M | $341.7M |
| 总资产 | $73.6M | $461.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BNGOCTKB
| Q4 25 | $3.0M | $90.9M | ||
| Q3 25 | $3.1M | $93.3M | ||
| Q2 25 | $3.6M | $75.5M | ||
| Q1 25 | $3.6M | $95.3M | ||
| Q4 24 | $9.2M | $98.7M | ||
| Q3 24 | $8.8M | $162.3M | ||
| Q2 24 | $10.4M | $177.9M | ||
| Q1 24 | $15.8M | $168.8M |
股东权益BNGOCTKB
| Q4 25 | $44.4M | $341.7M | ||
| Q3 25 | $49.8M | $378.6M | ||
| Q2 25 | $45.4M | $377.6M | ||
| Q1 25 | $48.2M | $379.6M | ||
| Q4 24 | $35.4M | $395.7M | ||
| Q3 24 | $48.9M | $385.5M | ||
| Q2 24 | $80.3M | $389.1M | ||
| Q1 24 | $82.8M | $392.6M |
总资产BNGOCTKB
| Q4 25 | $73.6M | $461.5M | ||
| Q3 25 | $79.1M | $494.9M | ||
| Q2 25 | $76.0M | $493.3M | ||
| Q1 25 | $78.4M | $482.6M | ||
| Q4 24 | $76.7M | $499.5M | ||
| Q3 24 | $87.4M | $491.2M | ||
| Q2 24 | $129.4M | $483.7M | ||
| Q1 24 | $158.0M | $492.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.8M |
| 自由现金流率自由现金流/营收 | — | -2.9% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.8M |
8季度趋势，按日历期对齐
经营现金流BNGOCTKB
| Q4 25 | $-4.2M | $-771.0K | ||
| Q3 25 | $-5.9M | $-3.9M | ||
| Q2 25 | $-3.5M | $108.0K | ||
| Q1 25 | $-2.8M | $-125.0K | ||
| Q4 24 | $-6.5M | $2.0M | ||
| Q3 24 | $-13.3M | $13.2M | ||
| Q2 24 | $-21.0M | $6.2M | ||
| Q1 24 | $-28.1M | $4.0M |
自由现金流BNGOCTKB
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $3.4M |
自由现金流率BNGOCTKB
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | — | 7.6% |
资本支出强度BNGOCTKB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 1.3% |
现金转化率BNGOCTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BNGO
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
